Soligenix
SNGX
#10223
Rank
ยฃ12.18 M
Marketcap
ยฃ1.21
Share price
-1.23%
Change (1 day)
-51.81%
Change (1 year)

Soligenix (SNGX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ2.77 Million

According to Soligenix's latest financial reports the company's total liabilities are ยฃ2.77 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Soligenix - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ3.86 M-32.34%
2023-12-31ยฃ5.71 M-58.76%
2022-12-31ยฃ13.84 M15.74%
2021-12-31ยฃ11.96 M0.97%
2020-12-31ยฃ11.84 M145.89%
2019-12-31ยฃ4.81 M45.22%
2018-12-31ยฃ3.31 M38.83%
2017-12-31ยฃ2.38 M2.75%
2016-12-31ยฃ2.32 M-53.46%
2015-12-31ยฃ4.99 M9.45%
2014-12-31ยฃ4.56 M-24.96%
2013-12-31ยฃ6.08 M752.1%
2012-12-31ยฃ0.71 M-22.54%
2011-12-31ยฃ0.92 M-25.53%
2010-12-31ยฃ1.23 M65.53%
2009-12-31ยฃ0.74 M-20.91%
2008-12-31ยฃ0.94 M57.37%
2007-12-31ยฃ0.6 M-53.22%
2006-12-31ยฃ1.28 M20.06%
2005-12-31ยฃ1.06 M-1.47%
2004-12-31ยฃ1.08 M92.79%
2003-12-31ยฃ0.56 M-41.85%
2002-12-31ยฃ0.96 M-89.73%
2001-12-31ยฃ9.42 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Emergent BioSolutions
EBS
ยฃ0.65 B 23,669.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ49.56 B 1,786,376.51%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
ยฃ86.80 B 3,128,603.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ85.22 B 3,071,892.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
ยฃ32.89 M 1,085.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
ยฃ9.12 M 228.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ24.47 B 882,003.06%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel